Hypertensive Vascular Disease

Slide 1 · Hypertensive Vascular Disease

Mechanisms, vascular remodeling, and target-organ injury

Mechanisms • Morphology • Clinicopathologic correlation

Dr Abu Suraih Sakhri

MBBS, MD (Pathology)

www.abusuraihsakhri.com

Slide 2 · Learning objectives

Explain how cardiac output, peripheral resistance, and renal sodium handling govern arterial pressure.

Distinguish essential from secondary hypertension and identify major etiologic categories.

Recognize hyaline and hyperplastic arteriolosclerosis, malignant hypertension, and organ injury.

Slide 3 · Pressure homeostasis: Two clinically important extremes

Low arterial pressure

Inadequate tissue perfusion

Functional impairment of vulnerable organs

Prolonged deficit may cause tissue death

High arterial pressure

Progressive vascular wall injury

Increased atherosclerotic risk

Target-organ dysfunction

Slide 4 · Arterial pressure is a continuous biologic variable

Blood pressure is continuously distributed in populations, rather than separated into natural normal and abnormal clusters.

Cardiovascular risk increases as blood pressure rises: A threshold is useful for decisions, but does not create risk de novo.

Risk depends on both the attained pressure and the accompanying clinical context.

Risk continuum

Lower pressure

Increasing pressure

Cardiovascular risk rises

Schematic

Slide 5 · Blood-pressure descriptions

Category

Systolic

Diastolic

Interpretive point

Normotensive example

<120 mm Hg

<80 mm Hg

Descriptive values in Robbins

Borderline elevated

120–130 mm Hg

—

Textbook wording; overlap at 130

Overt hypertension

≥130 mm Hg

or ≥90 mm Hg

Robbins definition; not universal clinical guidance

Slide 6 · Systolic and diastolic pressure both matter

Systolic pressure reflects the peak pressure imposed on arterial walls during ventricular ejection.

Diastolic pressure reflects arterial pressure during cardiac relaxation.

Robbins explicitly identifies both measurements as contributors to cardiovascular risk.

Two pressure components

Systole: Peak pressure

Diastole: Lower pressure

Both inform risk

Schematic

Slide 7 · The risk context modifies interpretation

A single pressure cutoff does not reliably determine every patient’s future vascular risk.

Coexisting factors, illustrated by diabetes in the source, can modify clinical thresholds and absolute risk.

Keep textbook descriptors separate from whichever formal clinical guideline is used in practice.

Interpretive framework

Pressure reading

Coexisting risk factors

Clinical risk assessment

Schematic

Slide 8 · Hypertension is common and becomes more consequential with age

That roughly one-third to one-half of adults in many populations meet its stated hypertension definition.

Both hypertension prevalence and vulnerability to complications rise with age.

Population estimates depend on the population studied and the diagnostic definition applied.

Slide 9 · Hypertension may remain clinically silent for years

Even very elevated pressure can exist without obvious symptoms for a prolonged period.

Absence of symptoms does not exclude injury to small vessels, heart, brain, or kidneys.

The first recognizable clinical event may reflect established target-organ disease.

Clinically silent progression

Elevated pressure over years

Few or no symptoms

Organ injury may accumulate

Schematic

Slide 10 · Two major etiologic groups

Essential hypertension

Approximately 90%–95% of cases

No single identifiable cause

Polygenic and environmental contributions

Secondary hypertension

Approximately 5%–10% of cases

Identifiable underlying disorder

Renal, endocrine, or other causes

Slide 11 · From inherited predisposition to sustained pressure

Genetic variants

Environmental exposures

Renal sodium handling

Volume and resistance

Sustained hypertension

Essential hypertension is a network-level phenotype rather than a one-gene disease.

Slide 12 · Secondary hypertension: Etiologic map

Renal

Endocrine

Cardiovascular / other

Renal artery stenosis

Primary aldosteronism

Aortic coarctation

Chronic kidney disease

Cushing syndrome

Aortic rigidity / volume expansion

Acute glomerulonephritis

Pheochromocytoma

Sleep apnea or neurologic causes

Polycystic kidney disease

Thyrotoxicosis

Pregnancy-induced hypertension

Slide 13 · Renal disease can drive systemic hypertension

Reduced perfusion from renal artery stenosis may initiate a renin-mediated pressor response.

Renal parenchymal disease can disrupt sodium balance and vascular regulation.

Renal vascular injury can also be a consequence of long-standing hypertension, creating a bidirectional relationship.

Two-way renal relationship

Renal disease

Altered pressure control

Renal vascular injury

Schematic

Slide 14 · Endocrine causes act through distinct pressor pathways

Primary aldosteronism promotes renal sodium and water retention.

Pheochromocytoma produces a catecholamine-associated hypertensive state.

Cushing syndrome, thyroid disease, and selected hormone exposures are listed causes.

Endocrine pressor signals

Mineralocorticoid excess

Catecholamine excess

Increased arterial pressure

Schematic

Slide 15 · Additional causes differential

Category

Examples

Practical reasoning

Cardiovascular

Aortic coarctation; increased cardiac output

Altered vascular structure or flow

Neurologic

Increased intracranial pressure; acute stress

Neural and sympathetic effects

Sleep-disordered breathing

Sleep apnea

Secondary contributor listed in Robbins

Pregnancy-associated

Preeclampsia

Distinct clinical context

Drug / hormonal exposures

Glucocorticoids, estrogens, sympathomimetics

Review exposure history

Slide 16 · Determinants of arterial pressure

Cardiac output

Arterial pressure

Peripheral resistance

Arterial pressure depends on BOTH cardiac output and systemic vascular resistance.

Slide 17 · Determinants of cardiac output

Heart rate

Cardiac output

Stroke volume

Stroke volume is influenced by ventricular filling and myocardial contractility.

Slide 18 · Why renal sodium handling changes cardiac output

Renal sodium retention leads to retention of water and expansion of intravascular volume.

Blood volume determines ventricular filling and thereby strongly influences stroke volume.

The kidney couples long-term salt balance to the cardiac component of blood pressure.

Cardiac-output linkage

Sodium retention

Water retention

Volume and stroke volume

Schematic

Slide 19 · The arterioles are key resistance vessels

Peripheral vascular resistance is regulated predominantly in small arteries and arterioles.

Vascular smooth-muscle contraction acutely changes arteriolar caliber.

Neural, hormonal, and local metabolic signals influence arteriolar tone.

Resistance-vessel regulation

Arteriolar smooth muscle

Lumen diameter

Peripheral resistance

Schematic

Slide 20 · Vasomotor mediators shape resistance

Predominant vasoconstrictors

Angiotensin II

Catecholamines

Endothelin

Predominant vasodilators

Nitric oxide

Kinins

Prostaglandins

Slide 21 · Autoregulation couples regional flow to local demand

Resistance vessels respond to variations in regional blood flow and perfusion pressure.

Increased flow may produce protective local vasoconstriction, limiting hyperperfusion.

Tissue pH and hypoxia help tailor perfusion to changing metabolic needs.

Local tissue regulation

Perfusion changes

Arteriolar tone adapts

Local flow matched to demand

Schematic

Slide 22 · Hormonal regulation integrates three organs

Kidney: Renin secretion and adjustable sodium excretion.

Adrenal cortex: Aldosterone-mediated renal sodium retention.

Heart: Natriuretic peptides that favor vasodilation and sodium excretion.

Organ-level interaction

Kidney: Renin / sodium

Adrenal: Aldosterone

Heart: ANP / BNP

Schematic

Slide 23 · Small adjustments in sodium excretion matter

Filtration of about 170 L plasma and 23 mol of salt each day.

With an illustrative 100 mEq daily dietary sodium intake, about 99.5% of filtered sodium must be reabsorbed.

Fine regulation of the remaining sodium reabsorption sets long-term net sodium balance.

Fine control of salt balance

High filtered sodium load

Precisely regulated reabsorption

Daily excretion matches intake

Schematic

Slide 24 · Juxtaglomerular renin release: Three stimuli

Reduced pressure in the renal afferent arteriole.

Elevated circulating catecholamine signaling.

Reduced sodium delivery to the distal renal tubule.

Juxtaglomerular stimulus

Low afferent pressure

Catecholamines / low distal Na⁺

Renin release

Schematic

Slide 25 · Renin–angiotensin cascade

Renin + angiotensinogen

Angiotensin I

ACE conversion

Angiotensin II

Pressor responses

Renin first cleaves angiotensinogen; ACE generates angiotensin II from angiotensin I.

Slide 26 · Three pressor actions of angiotensin II

Causes vascular smooth-muscle contraction and increases resistance.

Stimulates adrenal aldosterone secretion.

Increases renal tubular sodium reabsorption.

Angiotensin II effectors

Arteriolar constriction

Aldosterone secretion

Tubular Na⁺ retention

Schematic

Slide 27 · Aldosterone: Sodium to blood volume

Aldosterone signal

Distal nephron sodium reabsorption

Water retention

Higher blood volume

Higher arterial pressure

The principal pressor effect emphasized is expansion of extracellular and circulating volume.

Slide 28 · Natriuretic peptides counter sodium retention

Atrial natriuretic peptide is secreted by atrial myocardium; BNP rises particularly with ventricular volume overload.

These peptides favor systemic vasodilation and renal sodium excretion/diuresis.

Elevated circulating ANP or BNP can reflect volume overload, as in congestive heart failure.

Counter-regulatory response

Volume-stretched myocardium

ANP / BNP release

Vasodilation and natriuresis

Schematic

Slide 29 · Counter-regulatory pressure systems

Feature

RAAS predominance

Natriuretic peptide predominance

Trigger

Reduced renal perfusion / sodium delivery

Cardiac volume stretch

Resistance

Angiotensin II raises tone

Vasodilation

Sodium balance

Aldosterone promotes retention

Natriuresis / diuresis

Net directional effect

Tends to increase arterial pressure

Tends to decrease arterial pressure

Slide 30 · Renovascular hypertension: Causal sequence

Renal artery stenosis

Lower renal perfusion

Renin release

Angiotensin II / aldosterone

Higher pressure

The stenotic kidney may interpret local hypoperfusion as systemic underfilling.

Slide 31 · Primary aldosteronism: A sodium-retentive cause

Primary aldosteronism is listed among the frequent identifiable endocrine causes.

It may be idiopathic or associated with an aldosterone-secreting adrenal adenoma.

Enhanced distal sodium reabsorption expands volume and contributes to hypertension.

Mineralocorticoid pathway

Aldosterone elevation

Distal sodium retention

Volume expansion

Schematic

Slide 32 · Rare monogenic hypertensive phenotypes

Single-gene disorders can perturb aldosterone metabolism or renal epithelial sodium transport.

Some steroidogenic enzyme defects produce an excess mineralocorticoid effect.

Liddle syndrome exemplifies ENaC-related increased distal nephron sodium reabsorption.

Rare inherited mechanisms

Steroidogenic enzymes

ENaC sodium transport

Potential monogenic hypertension

Schematic

Slide 33 · Essential hypertension has a polygenic substrate

Twin and family/adoption observations support heritable variation in blood pressure.

More than 500 blood-pressure-associated variants from genome-wide association studies.

Each contribution must be interpreted within interacting environmental and physiologic networks.

Essential-disease substrate

Many associated alleles

Environmental exposures

Shared BP physiology

Schematic

Slide 34 · Pressure natriuresis can reset at higher pressure

Impaired Na⁺ excretion at baseline

Fluid-volume expansion

Higher cardiac output

Resistance adaptation

New high-pressure balance

Sodium excretion again matches intake, but only at an elevated pressure set point.

Slide 35 · Increased vascular resistance reinforces hypertension

Sustained vasoconstrictor influences elevate arteriolar tone.

Structural changes of resistance-vessel walls may further increase resistance.

Volume-dependent and resistance-dependent influences can reinforce one another.

Resistance pathway

Sustained vasoconstriction

Vascular wall remodeling

Elevated resistance

Schematic

Slide 36 · Environmental factors highlighted by Robbins

Factor

Pathophysiologic connection

High dietary sodium

Greater sodium burden when excretory adjustment is impaired

Obesity

Complex interaction with volume and neurohormonal regulation

Physical inactivity

Associated with essential-hypertension risk

Smoking

Vascular and cardiovascular risk contribution

Stress

Neural and hormonal pressure influences

Slide 37 · Convergence of essential-hypertension pathways

Genetic predisposition

Sodium retention

Volume / flow response

Arteriolar resistance

Sustained high pressure

Genetic and environmental influences converge on sodium and vascular regulation.

Slide 38 · Mechanistic comparison: Essential vs secondary

Essential disease

No single initiating lesion can be assigned

Multiple genetic and environmental influences

Common final pathways: Sodium, volume, resistance

Secondary disease

An identifiable driver exists

Renal stenosis, endocrine disorder or other cause

Specific causal pathway may be established

Slide 39 · Vascular injury can be both cause and consequence

Chronic hemodynamic stress promotes endothelial dysfunction and structural adaptation.

Small-vessel luminal narrowing compromises distal perfusion.

Reduced renal perfusion may further sustain pressor pathways.

Positive-feedback potential

Vascular injury

Luminal restriction

Renal perfusion changes

Schematic

Slide 40 · Why hypertension produces target-organ damage

Increased pressure accelerates atherogenesis in susceptible large and medium arteries.

Arterial and arteriolar remodeling can narrow vessel lumens and cause ischemia.

Sudden severe pressure elevation may produce vascular wall necrosis and acute organ failure.

Injury pathway

High arterial pressure

Wall injury / remodeling

Distal organ dysfunction

Schematic

Slide 41 · Cardiac consequences: Pressure overload

Long-standing hypertension is associated with cardiac hypertrophy.

Progressive cardiac dysfunction may culminate in heart failure.

Atherosclerotic cardiovascular disease contributes additional ischemic risk.

Cardiac response

Chronic pressure load

Myocardial hypertrophy

Heart failure risk

Schematic

Slide 42 · Brain and cerebrovascular complications

Elevated pressure contributes to cerebrovascular hemorrhage.

Hypertension increases atherosclerotic and ischemic cerebrovascular risk.

Chronic vascular disease is associated with multi-infarct dementia.

Cerebrovascular injury

Vascular wall injury

Occlusion / hemorrhage

Neurologic consequences

Schematic

Slide 43 · Kidney injury: Microvascular to parenchymal disease

Arteriolar wall thickening narrows renal microvascular lumens.

Diffuse loss of renal blood supply can cause glomerular scarring.

Chronic nephrosclerosis may progress to renal functional impairment.

Renal consequence

Arteriolar narrowing

Glomerular ischemia

Glomerular scar

Schematic

Slide 44 · Large- and medium-artery consequences

Hypertension accelerates atherogenesis and the associated ischemic burden.

Chronic hemodynamic stress contributes to arterial wall degeneration.

Aortic dissection and cerebrovascular hemorrhage are important consequences listed.

Major-artery consequence

Chronic arterial stress

Atherogenesis and degeneration

Major-artery complications

Schematic

Slide 45 · Organ-based map of hypertensive disease

Tissue

Illustrative injury

Pathology linkage

Heart

Hypertrophy; heart failure

Pressure load and ischemic disease

Brain

Stroke; multi-infarct damage

Vascular injury and occlusion / rupture

Kidney

Nephrosclerosis; renal failure

Arteriolar narrowing and glomerular scarring

Aorta

Dissection

Degenerative wall injury

Retina

Hemorrhages and exudates in severe disease

Small-vessel target-organ injury

Slide 46 · Chronic vs rapidly progressive disease

Long-standing hypertension

Often clinically silent

Cumulative vascular and organ remodeling

Hyaline arteriolosclerosis is common

Malignant hypertension

Rapidly escalating, very high pressure

Acute kidney and retinal injury

Hyperplastic changes with necrosis may occur

Slide 47 · Malignant hypertension: Source-defined phenotype

Rapidly rising, severe blood pressure—often >180 mm Hg systolic and >120 mm Hg diastolic.

Associated renal failure and retinal hemorrhages/exudates are defining features in the source.

Papilledema may be present but is not obligatory in the described syndrome.

Organ-threatening phenotype

Marked and rising pressure

Retinal / renal injury

Destructive microvascular lesions

Schematic

Slide 48 · Malignant hypertension can complicate prior disease

The syndrome may develop in previously normotensive individuals.

More commonly, it supervenes on preexisting hypertension described historically as “benign.”

The malignant descriptor reflects rapidly progressive organ-threatening injury, not neoplasia.

Time course

Preexisting HTN possible

Rapid pressure escalation

Severe organ damage

Schematic

Slide 49 · Severe-pressure microvascular injury sequence

Abrupt severe pressure stress

Endothelial and vessel-wall damage

Concentric wall remodeling

Luminal compromise

Ischemia / organ failure

Fibrinoid injury and necrosis may accompany the hyperplastic lesion in malignant disease.

Slide 50 · Retina and kidney are defining target organs

Retinal hemorrhages and exudates are named manifestations of the malignant syndrome.

Papilledema may occur and should be separately recognized.

Renal failure signals severe renal vascular and parenchymal injury.

Target-organ evidence

Retinal hemorrhages / exudates

Renal dysfunction

Malignant syndrome

Schematic

Slide 51 · Pulmonary hypertension is a distinct vascular setting

Pulmonary pressure elevation has causes including left-heart disease, congenital defects, valvular disease, lung disorders and thromboembolism.

Pulmonary arterioles can display intimal fibrosis and medial hyperplasia.

These findings should not be substituted for systemic hypertensive arteriolosclerosis without the relevant context.

Pulmonary vascular bed

Pulmonary vascular pressure

Intimal / medial remodeling

Distinct etiologic work-up

Schematic

Slide 52 · Hypertension-related arteriolar lesion spectrum

Hyaline arteriolosclerosis: Amorphous eosinophilic wall thickening with luminal loss.

Hyperplastic arteriolosclerosis: Concentric laminated wall thickening in severe hypertension.

Necrotizing arteriolitis: Destructive vascular wall lesion, especially emphasized in renal disease.

Three named lesions

Hyaline thickening

Concentric hyperplasia

Necrotizing damage

Schematic

Slide 53 · Normal arteriole: The baseline for comparison

Reference arteriole

Normal anatomy

Recognition points

Patent lumen bounded by a relatively thin muscular wall

Endothelium at the blood–wall interface

Useful reference for recognizing pathological wall-to-lumen ratios

Schematic cross-sections; Not photomicrographs

Slide 54 · Hyaline arteriolosclerosis: Two contributors

Chronic pressure injury

Plasma protein leakage

SMC matrix synthesis

Hyaline wall thickening

Two parallel processes contribute to the homogeneous, thickened wall and narrowed lumen.

Slide 55 · Hyaline arteriolosclerosis: Diagnostic schematic

Reference arteriole

Hypertension-associated lesion

Recognition points

Homogeneous eosinophilic-appearing material accumulates in arteriolar walls

Wall thickening is predominantly acellular / glassy

Luminal narrowing reduces downstream tissue perfusion

Schematic cross-sections; Not photomicrographs

Slide 56 · Hyalinosis is not exclusive to hypertension

Arteriolar hyalinosis may be encountered with advancing age even without hypertension.

It is more generalized and severe in patients with hypertension and diabetes.

Attribution requires the broader clinical and renal parenchymal context.

Clinicopathologic context

Older age

Hypertension / diabetes

Arteriolar hyalinosis

Schematic

Slide 57 · Chronic hypertensive nephrosclerosis

Arteriolar hyalinosis

Luminal narrowing

Diffuse renal hypoperfusion

Glomerular scarring

Declining renal reserve

The microvascular lesion explains why apparently indolent pressure elevation causes cumulative renal disease.

Slide 58 · Hyperplastic arteriolosclerosis: Diagnostic schematic

Reference arteriole

Hypertension-associated lesion

Recognition points

Concentric, laminated “onion-skin” wall thickening

Smooth-muscle cells and reduplicated basement membranes form the layers

Severe luminal narrowing accompanies severe hypertension

Schematic cross-sections; Not photomicrographs

Slide 59 · Why onion-skin laminations form

Sustained severe hemodynamic injury stimulates vessel-wall cellular and matrix responses.

Concentric smooth-muscle proliferation and basement-membrane reduplication create stacked lamellae.

The narrowing lumen is a functional consequence, not a merely decorative histologic feature.

Microscopic architecture

SMC accumulation

Basement membrane reduplication

Concentric wall laminations

Schematic

Slide 60 · Fibrinoid deposits indicate destructive injury

In malignant hypertension, hyperplastic change may be accompanied by fibrinoid deposition.

Vascular wall necrosis marks acute, severe microvascular damage.

Fibrinoid necrosis should be distinguished morphologically from chronic, non-necrotizing hyaline material.

Severe injury

Severe endothelial injury

Fibrinoid deposition

Wall necrosis may occur

Schematic

Slide 61 · Necrotizing arteriolitis: An important renal lesion

Necrotizing arteriolitis as a third hypertension-related small-vessel lesion.

It is highlighted particularly in the kidney.

This lesion belongs to the severe injury spectrum and is distinct from simple luminal hyalinosis.

Necrotizing spectrum

Severe pressure-associated injury

Arteriolar wall necrosis

Renal microvascular dysfunction

Schematic

Slide 62 · Small-vessel lesions compared

Feature

Hyaline

Hyperplastic

Necrotizing

Typical setting

Chronic HTN; also aging/diabetes

Severe HTN

Severe destructive injury

Dominant change

Glassy eosinophilic wall material

Concentric lamellated thickening

Wall necrosis

Key source mechanism

Protein leakage + matrix synthesis

SMC proliferation + basement membrane

Fibrinoid injury / necrosis

Clinical link

Chronic ischemia; nephrosclerosis

Marked luminal narrowing

Acute organ-threatening microvascular injury

Slide 63 · Do not confuse patterns of arteriosclerosis

Pattern

Principal arterial level / change

Relation to hypertension

Arteriolosclerosis

Small arteries and arterioles

Hyaline / hyperplastic forms

Atherosclerosis

Intimal atheromatous plaques

Hypertension accelerates risk

Mönckeberg medial sclerosis

Medial calcification, often little lumen change

Different process

Fibromuscular intimal hyperplasia

Repair-associated intimal SMC / ECM thickening

Mechanical/inflammatory injury response

Slide 64 · A pathology report must be interpreted in context

Arteriolar hyalinosis is a descriptive morphologic finding, not a unique test for hypertension.

Concentric arteriolar proliferation should prompt attention to severity and acute vascular injury.

Glomerulosclerosis, tubulointerstitial change, diabetes, and large-vessel disease may modify interpretation.

Diagnostic integration

Morphologic lesion

Clinical context

Integrated pathology interpretation

Schematic

Slide 65 · Application: Prolonged, silent hypertension

Clinical / pathology stem

A patient has had years of minimally symptomatic elevated pressure. Renal microscopy shows diffuse homogeneous pink thickening of arteriolar walls and small lumina.

Which vascular lesion best explains reduced renal perfusion?

Interpretation

Hyaline arteriolosclerosis: Wall protein leakage and SMC-derived matrix contribute to narrowing and chronic nephrosclerosis.

Slide 66 · Application: Renovascular hypertension

Clinical / pathology stem

A patient has narrowing of a main renal artery. The affected kidney experiences reduced afferent perfusion despite high systemic pressure.

What renal signal amplifies systemic pressure?

Interpretation

Renin release → angiotensin II → vasoconstriction and aldosterone-mediated sodium retention.

Slide 67 · Application: Abrupt severe hypertension

Clinical / pathology stem

A patient develops rapid, marked pressure elevation together with renal dysfunction and retinal hemorrhages. Renal arterioles are concentrically laminated.

Name the syndrome and explain the characteristic arteriolar lesion.

Interpretation

Malignant hypertension; Hyperplastic arteriolosclerosis is an onion-skin lesion and may accompany fibrinoid injury.

Slide 68 · Integrated pathologic reasoning

Identify the pressure pattern and whether an underlying cause is recognizable.

Connect renal sodium regulation and arteriolar resistance to persistent pressure elevation.

Interpret arteriolar morphology alongside target-organ findings and clinical tempo.

Three-part interpretation

Pressure phenotype

Etiologic pathway

Morphology + organ injury

Schematic

Slide 69 · Selected sources and diagnostic-image references

Source

Role

Robbins, Cotran & Kumar, Pathologic Basis of Disease, 11th ed., Ch 11, pp 445–448

Primary source for lecture text and diagrams

Wikimedia Commons: “Histopathology of renal arteriolar hyalinosis” (M. Häggström; CC0)

Authentic specimen reference; NOT embedded

Wikimedia Commons: “Onion-skin renal arteriole” (Pacolarosa; CC BY-SA 3.0)

Authentic specimen reference; NOT embedded